Is BFFTF or JNJ a better dividend investment in 2026?

BFFTF currently yields 606.06% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: BFFTF offers higher current income.

What is the dividend yield difference between BFFTF and JNJ?

BFFTF has a forward dividend yield of 606.06% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 602.70 percentage points.

Home › Compare › BFFTF vs JNJ

BFFTF vs JNJ: Dividend Comparison 2026

BFFTF yields 606.06% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 BFFTF wins by $280371.15M in total portfolio value

INVESTMENT

TIME HORIZON10 years

BFFTF

● Live price

606.06%

Share price

$0.33

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$280371.17M

Annual income

$211,667,981,687.60

Full BFFTF calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — BFFTF vs JNJ

📍 BFFTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	BFFTF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, BFFTF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

BFFTF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BFFTF

Annual income on $10K today (after 15% tax)

$51,515.15/yr

After 10yr DRIP, annual income (after tax)

$179,917,784,434.46/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, BFFTF beats the other by $179,917,783,730.85/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BFFTF + JNJ for your $10,000?

BFFTF: 50%JNJ: 50%

100% JNJ50/50100% BFFTF

Portfolio after 10yr

$140185.59M

Annual income

$105,833,991,257.69/yr

Blended yield

75.50%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BFFTF

Analyst Ratings

Buy

Consensus: Buy

Altman Z

-7.4

Piotroski

2/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BFFTF buys

JNJ buys

No recent congressional trades found for BFFTF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricBFFTFJNJ

Forward yield	606.06% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$280371.17M ✓	$20.0K
Annual income after 10y	$211,667,981,687.60 ✓	$827.78
Total dividends collected	$274648.71M ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Buy	Buy

Year-by-year: BFFTF vs JNJ ($10,000, DRIP)

Year	BFFTF Portfolio	BFFTF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$71,306	$60,606.06	$10,676	$355.77	+$60.6K → BFFTF
2	$480,183	$403,885.93	$11,407	$389.39	+$468.8K → BFFTF
3	$3,055,680	$2,541,883.57	$12,198	$426.53	+$3.04M → BFFTF
4	$18,386,820	$15,117,242.14	$13,056	$467.62	+$18.37M → BFFTF
5	$104,687,331	$85,013,433.96	$13,987	$513.12	+$104.67M → BFFTF
6	$564,382,839	$452,367,394.46	$14,998	$563.56	+$564.37M → BFFTF
7	$2,883,114,581	$2,279,224,943.60	$16,098	$619.52	+$2883.10M → BFFTF
8	$13,966,501,456	$10,881,568,854.67	$17,295	$681.69	+$13966.48M → BFFTF
9	$64,208,586,900	$49,264,430,341.75	$18,599	$750.82	+$64208.57M → BFFTF
10	$280,371,169,670	$211,667,981,687.60	$20,022	$827.78	+$280371.15M → BFFTF

BFFTF vs JNJ: Complete Analysis 2026

BFFTF — Stock

Biofrontera AG, a biopharmaceutical company, engages in the research, development, and marketing of dermatological products. Its products include Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma. The company also develops RhodoLED XL for the treatment of multiple interspersed lesions; Belixos, a modern active cosmetic product for irritated and sensitive skin; and Xepi for the treatment of antibiotic-resistant bacteria. It offers its products primarily in the United States, Europe, and Israel. The company has a collaboration and partnership agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany.

Full BFFTF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this BFFTF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BFFTF vs SCHD BFFTF vs JEPI BFFTF vs O BFFTF vs KO BFFTF vs MAIN BFFTF vs ABBV BFFTF vs MRK BFFTF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.